Basics FibroGen, Inc FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. IPO Date: November 14, 2014 Sector: Healthcare Industry: Biotech Market Cap: $45.09M Activated in VL: True Average Daily Range Avg Daily Range: $0.62 | 3.05% Avg Daily Range (30 D): $0.29 | 2.55% Avg Daily Range (90 D): $0.33 | 3.80% Institutional Daily Volume Avg Daily Volume: .87M Avg Daily Volume (30 D): .02M Avg Daily Volume (90 D): .04M Trade Size Avg Trade Size (Sh.): 137 Avg Trade Size (Sh.) (30 D): 101 Avg Trade Size (Sh.) (90 D): 115 Institutional Trades Total Inst.Trades: 4,003 Avg Inst. Trade: $2.19M Avg Inst. Trade (30 D): $.84M Avg Inst. Trade (90 D): $.84M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.9M Avg Closing Trade (30 D): $9.03M Avg Closing Trade (90 D): $9.03M Avg Closing Volume: 4.91K     News Aug 18, 2025 @ 11:00 AM FibroGen Announces Approval of Sale of FibroGen Ch... Source: Fibrogen, Inc. Feb 20, 2025 @ 6:08 PM Amid Mounting Pressure In China, AstraZeneca Buys ... Source: Vandana Singh Sep 2, 2024 @ 8:15 PM Liver Fibrosis Market Is Expected to Reach USD 43.... Source: The Brainy Insights Aug 23, 2024 @ 10:04 PM Catalyst Accelerator Ogden Selects 11 Companies fo... Source: Catalyst Accelerator Ogden Jun 3, 2024 @ 8:48 PM FibroGen Stock Is Surging After The Bell: What's G... Source: Adam Eckert Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.72 $-1.88 $.05 Diluted EPS $-.72 $-1.88 $.05 Revenue $ -72.84M $ 1.35M $ 2.74M Gross Profit $ -57.8M $ 1.26M $ 2.49M Net Income / Loss $ -2.07M $ -7.6M $ 4.64M Operating Income / Loss $ -135.41M $ -12.05M $ -14.92M Cost of Revenue $ -15.03M $ .09M $ .25M Net Cash Flow $ 41.53M $ 12.66M $ 2.62M PE Ratio     Splits Jun 17, 2025:   1:25